Outpatient Prescription Drug Benefit Sample Clauses

Outpatient Prescription Drug Benefit. Subject to the terms and conditions of this Section, bene- fits are provided for outpatient prescription Drugs, which are prescribed by a licensed Physician and are obtained from a Participating Pharmacy. Benefits are provided for Formulary Drugs, which are Drugs listed on Blue Shield’s Drug Formulary. This Formulary is updated on a periodic basis by Blue Shield’s Pharmacy and Thera- peutics Committee. Benefits may also be provided for Non-Formulary Drugs subject to higher Copayments. Select Drugs and Drug dosages and most Home Self- Administered Injectables require prior authorization by Blue Shield of California for Medical Necessity appro- priateness of therapy or when effective, lower cost alter- natives are available. Your Physician may request prior authorization from Blue Shield. Coverage for selected Drugs may be limited to a specific quantity as described in the section entitled Limitation on Quantity of Drugs that May be Obtained per Prescription or Refill.
AutoNDA by SimpleDocs
Outpatient Prescription Drug Benefit. Medically Necessary outpatient prescription drugs and insulin are covered when prescribed by a Provider licensed to prescribe federal legend prescription drugs or medicines subject to the terms, HMO policies, Exclusions and Limitations section described in this rider and the EOC. Coverage is based on HMO’s determination that a prescription drug is Medically Necessary. Some items are covered only with Precertification from HMO. Items covered by this rider are subject to drug utilization review by HMO and/or Member’s Participating Provider and/or Member’s Participating Retail or Mail Order Pharmacy. Non-emergency and non-Urgent Care prescriptions will be covered only when filled at a Participating Retail Pharmacy or the Participating Mail Order Pharmacy. Members are required to present their ID card at the time the prescription is filled and pay the applicable Copayment. Members who have lost or misplaced their ID Card may call Member Services at 0- 000-000-0000 for a replacement card and for pharmacy authorizations. A Member who fails to identify themselves as covered by presenting the ID card, or requesting that the Participating Retail Pharmacy contact HMO for verification of coverage will not receive reimbursement for the entire amount of out-of-pocket expenses. HMO will deduct any applicable Copayments, and will reimburse the member for the Contracted Rate for the prescription. Please refer to the EOC for a description of emergency and Urgent Care coverage. HMO retains the right to review all requests for reimbursement and make reimbursement determinations subject to the Claim Procedures/Complaints and Appeals section of the EOC. Precertification: Certain prescription drugs on the Precertification List are covered only when Precertified by HMO. Member’s Participating Physician or Participating Retail or Mail Order Pharmacy (for certain antibiotics) may request Precertification to obtain coverage for drugs on the Precertification List. Prescription drugs on the Step Therapy Program list will be covered if Member’s prescribing Provider requests Prior Authorization. Such Precertification or Prior Authorization requests shall be made by the Provider to the precertification department of HMO’s Pharmacy Management Department. The Pharmacy Management Department will respond to complete Precertification/Prior Authorization requests within 24 hours of receipt, based upon the nature of the member’s medical condition. Coverage granted as a result of Precertificati...

Related to Outpatient Prescription Drug Benefit

  • Prescription Drug Plan Effective January 1, 2022, retail and mail order prescription drug copays for bargaining unit employees shall be as follows: Type of Drug Prescriptions for 1-45 Days (1 copay) Prescriptions for 46-90 Days (2 copays) Generic drug $10 $20 Preferred brand name drug $25 $50 Non- referred brand name drug $40 $80 Effective January 1, 2022, for each plan year the Prescription Drug annual out-of-pocket copay maximum shall be $1,000 for individual coverage and $1,500 for employee and spouse, employee and child, or employee and family coverage.

  • Prescription Drugs The agreement may impose a variety of limits affecting the scope or duration of benefits that are not expressed numerically. An example of these types of treatments limit is preauthorization. Preauthorization is applied to behavioral health services in the same way as medical benefits. The only exception is except where clinically appropriate standards of care may permit a difference. Mental disorders are covered under Section A. Mental Health Services. Substance use disorders are covered under Section

  • Alcohol and Drug Testing Employee agrees to comply with and submit to any Company program or policy for testing for alcohol abuse or use of drugs and, in the absence of such a program or policy, to submit to such testing as may be required by Company and administered in accordance with applicable law and regulations.

  • Outpatient If you receive dialysis services in a hospital's outpatient unit or in a dialysis facility, we cover the use of the treatment room, related supplies, solutions, drugs, and the use of the dialysis machine. In Your Home If you receive dialysis services in your home and the services are under the supervision of a hospital or outpatient facility dialysis program, we cover the purchase or rental (whichever is less, but never to exceed our allowance for purchase) of the dialysis machine, related supplies, solutions, drugs, and necessary installation costs. Related Exclusions If you receive dialysis services in your home, this agreement does NOT cover: • installing or modifying of electric power, water and sanitary disposal or charges for these services; • moving expenses for relocating the machine; • installation expenses not necessary to operate the machine; or • training you or members of your family in the operation of the machine. This agreement does NOT cover dialysis services when received in a doctor’s office.

  • Prescription Safety Glasses Prescription safety glasses will be furnished by the employer. The employer retains the authority to establish reasonable rules and procedures regarding frequency of issue, replacement of damaged glasses, limits on reimbursement costs and coordination with the employer's vision plan.

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

  • Substance Abuse Program The SFMTA General Manager or designee will manage all aspects of the FTA-mandated Substance Abuse Program. He/she shall have appointing and removal authority over all personnel working for the Substance Abuse Program personnel, and shall be responsible for the supervision of the SAP.

  • DRUG/ALCOHOL TESTING 8.1 The parties agree that the maintenance of a drug/alcohol free work place is a goal of both the College and the Union. Employees are prohibited from possession, consumption and/or being under the influence of a controlled substance/alcohol while on the College’s premises or during time paid by the employer. Violations of this prohibition may result in a disciplinary action up to and including termination.

  • Prescription Claims against the Issuer or any Guarantor for the payment of principal or Additional Amounts, if any, on the Notes will be prescribed ten years after the applicable due date for payment thereof. Claims against the Issuer or any Guarantor for the payment of interest on the Notes will be prescribed five years after the applicable due date for payment of interest.

  • Study Population ‌ Infants who underwent creation of an enterostomy receiving postoperative care and awaiting enterostomy closure: to be assessed for eligibility: n = 201 to be assigned to the study: n = 106 to be analysed: n = 106 Duration of intervention per patient of the intervention group: 6 weeks between enterostomy creation and enterostomy closure Follow-up per patient: 3 months, 6 months and 12 months post enterostomy closure, following enterostomy closure (12-month follow-up only applicable for patients that are recruited early enough to complete this follow-up within the 48 month of overall study duration).

Time is Money Join Law Insider Premium to draft better contracts faster.